These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35862953)

  • 1. Zika Virus Replication in a Mast Cell Model is Augmented by Dengue Virus Antibody-Dependent Enhancement and Features a Selective Immune Mediator Secretory Profile.
    Coish JM; Crozier RWE; Schieffelin JS; Coorssen JR; Hunter FF; MacNeil AJ
    Microbiol Spectr; 2022 Aug; 10(4):e0177222. PubMed ID: 35862953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection.
    Khandia R; Munjal A; Dhama K; Karthik K; Tiwari R; Malik YS; Singh RK; Chaicumpa W
    Front Immunol; 2018; 9():597. PubMed ID: 29740424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dominant role for FcgammaRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release.
    Brown MG; King CA; Sherren C; Marshall JS; Anderson R
    J Leukoc Biol; 2006 Dec; 80(6):1242-50. PubMed ID: 16940332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Dual-Approach Strategy to Optimize the Safety and Efficacy of Anti-Zika Virus Monoclonal Antibody Therapeutics.
    Sun H; Yang M; Lai H; Neupane B; Teh AY; Jugler C; Ma JK; Steinkellner H; Bai F; Chen Q
    Viruses; 2023 May; 15(5):. PubMed ID: 37243242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy facilitates antibody-enhanced dengue virus infection in human pre-basophil/mast cells.
    Fang YT; Wan SW; Lu YT; Yao JH; Lin CF; Hsu LJ; Brown MG; Marshall JS; Anderson R; Lin YS
    PLoS One; 2014; 9(10):e110655. PubMed ID: 25329914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dengue Virus-Specific Antibodies Enhance Brazilian Zika Virus Infection.
    Castanha PMS; Nascimento EJM; Braga C; Cordeiro MT; de Carvalho OV; de Mendonça LR; Azevedo EAN; França RFO; Dhalia R; Marques ETA
    J Infect Dis; 2017 Mar; 215(5):781-785. PubMed ID: 28039355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dengue virus selectively induces human mast cell chemokine production.
    King CA; Anderson R; Marshall JS
    J Virol; 2002 Aug; 76(16):8408-19. PubMed ID: 12134044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
    Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
    Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: Panacea or Pandora's box?
    Gunawardana SA; Shaw RH
    BMC Infect Dis; 2018 Dec; 18(1):641. PubMed ID: 30526531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zika Virus-Induced Antibody Response Enhances Dengue Virus Serotype 2 Replication In Vitro.
    Kawiecki AB; Christofferson RC
    J Infect Dis; 2016 Nov; 214(9):1357-1360. PubMed ID: 27521359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus.
    Dejnirattisai W; Supasa P; Wongwiwat W; Rouvinski A; Barba-Spaeth G; Duangchinda T; Sakuntabhai A; Cao-Lormeau VM; Malasit P; Rey FA; Mongkolsapaya J; Screaton GR
    Nat Immunol; 2016 Sep; 17(9):1102-8. PubMed ID: 27339099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-Dependent Dengue Virus Entry Modulates Cell Intrinsic Responses for Enhanced Infection.
    Chan CYY; Low JZH; Gan ES; Ong EZ; Zhang SL; Tan HC; Chai X; Ghosh S; Ooi EE; Chan KR
    mSphere; 2019 Sep; 4(5):. PubMed ID: 31533998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conceptual model for optimizing vaccine coverage to reduce vector-borne infections in the presence of antibody-dependent enhancement.
    Tang B; Huo X; Xiao Y; Ruan S; Wu J
    Theor Biol Med Model; 2018 Sep; 15(1):13. PubMed ID: 30173664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of flavivirus vaccine-induced immunity on primary Zika virus antibody response in humans.
    Malafa S; Medits I; Aberle JH; Aberle SW; Haslwanter D; Tsouchnikas G; Wölfel S; Huber KL; Percivalle E; Cherpillod P; Thaler M; Roßbacher L; Kundi M; Heinz FX; Stiasny K
    PLoS Negl Trop Dis; 2020 Feb; 14(2):e0008034. PubMed ID: 32017766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors.
    Li M; Zhao L; Zhang C; Wang X; Hong W; Sun J; Liu R; Yu L; Wang J; Zhang F; Jin X
    PLoS One; 2018; 13(7):e0200478. PubMed ID: 30044839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-Reactive Dengue Virus Antibodies Augment Zika Virus Infection of Human Placental Macrophages.
    Zimmerman MG; Quicke KM; O'Neal JT; Arora N; Machiah D; Priyamvada L; Kauffman RC; Register E; Adekunle O; Swieboda D; Johnson EL; Cordes S; Haddad L; Chakraborty R; Coyne CB; Wrammert J; Suthar MS
    Cell Host Microbe; 2018 Nov; 24(5):731-742.e6. PubMed ID: 30439342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA sensors enable human mast cell anti-viral chemokine production and IFN-mediated protection in response to antibody-enhanced dengue virus infection.
    Brown MG; McAlpine SM; Huang YY; Haidl ID; Al-Afif A; Marshall JS; Anderson R
    PLoS One; 2012; 7(3):e34055. PubMed ID: 22479521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Tale of Two Viruses: Does Heterologous Flavivirus Immunity Enhance Zika Disease?
    Sariol CA; Nogueira ML; Vasilakis N
    Trends Microbiol; 2018 Mar; 26(3):186-190. PubMed ID: 29122447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuraminidase augments Fc gamma receptor II-mediated antibody-dependent enhancement of dengue virus infection.
    Mady BJ; Kurane I; Erbe DV; Fanger MW; Ennis FA
    J Gen Virol; 1993 May; 74 ( Pt 5)():839-44. PubMed ID: 8492089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.